[1] M.S. Freag, Y.S.R. Elnaggar, O.Y. Abdallah, Development of novel polymer-stabilized diosmin nanosuspensions: In vitro appraisal and ex vivo permeation, Int. J. Pharm. 454 (2013) 462-471.[2] A.A. Bunacio, G.E. Udristioiu, L.L. Ruta, S. Fleschin, H.Y. Aboul-Enein, Determination of diosmin in pharmaceutical formulations using Fourier transform infrared spectrophotometry, Saudi Pharm. J. 17 (2009) 303-306.[3] M.A. Campanero,M. Escolar, G. Perez, E. Garcia-Quetglas, B. Sadaba, J.R. Azana, Simultaneous determination of diosmin and disometin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study, J. Pharm. Biomed. Anal. 51 (2010) 875-881.[4] K.A. Lyseng-Williamson, C.M. Perry,Micronised purified flavonoid fraction: A review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids, Drugs 63 (2003) 71-100.[5] T.D. Dung, C.H. Day, T.V. Binh, C.H. Lin, X. Lin, C. Su, Y. Lin, F. Tsai,W. Kuo, X. Li, C. Kuo, PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression, Food Chem. Toxicol. 50 (2012) 1802-1810.[6] R.C. Garner, J.V.Garner, S. Gregory, M.Whattam, A. Calam, D. Leong, Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting, J. Pharm. Sci. 91 (2002) 32-40.[7] M.S. Freag, Y.S.R. Elnaggar, O.Y. Abdallah, Lyophilized self-phytosomal nanocarriers (LSPNs) as platforms for enhanced diosmin delivery: Optimization and ex-vivo permeation, Int. J. Nanomed. 8 (2013) 2385-2397.[8] A.R. Jassbi, R. Miri,M. Asadollahi, N. Javanmardi, O. Firuzi, Cytotoxic, antioxidant and antimicrobial effects of nine species of woundwort (Stachys) plants, Pharm. Biol. 52 (2014) 62-67.[9] U.C.S. Yadav, N.Z. Baquer, Pharmacological effects of Trigonella foenumgraecum L. in health and disease, Pharm. Biol. 52 (2014) 243-254.[10] J.A. Jimenez, F.Martinez, Thermodynamic study of the solubility of acetaminophen in propylene glycol+water cosolvent mixtures, J. Braz. Chem. Soc. 17 (2006) 125-134.[11] F. Shakeel, F.K. Alanazi, I.A. Alsarra, N. Haq, Thermodynamics-based mathematical model for solubility prediction of glibenclamide in ethanol-water mixtures, Pharm. Dev. Technol. 19 (2014) 702-707.[12] F. Shakeel, F.K. Alanazi, I.A. Alsarra, N. Haq, Solubility prediction of indomethacin in PEG 400 + water mixtures at various temperatures, J. Mol. Liq. 188 (2013) 28-32.[13] S. Soltanpour, A. Jouyban, Solubility of lamotrigine in binary and ternary mixtures of N-methyl pyrrolidone and water with polyethylene glycols 200, 400 and 600 at 298.2 K, J. Mol. Liq. 180 (2013) 1-6.[14] A. Apelblat, E. Manzurola, Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic and p-toluic acid and magnesium-DL-aspartate in water from T = (278 to 348) K, J. Chem. Thermodyn. 31 (1999) 85-91.[15] E.A. Cantillo, D.R. Delgado, F. Martinez, Solution thermodynamics of indomethacin in ethanol + propylene glycol mixtures, J. Mol. Liq. 181 (2013) 62-67.[16] C.L. Zhang, F. Zhao, Y.Wang, Thermodynamics of the solubility of sulfamethazine in methanol, ethanol, 1-propanol, acetone and chloroform from 293.15 to 333.15 K, J. Mol. Liq. 159 (2011) 170-172.[17] N. Sunsandee, M. Hronec, M. Stolcova, N. Leepipatpiboon, U. Pancharoen, Thermodynamics of the solubility of 4-acetyl benzoic acid in different solvents from 303.15 to 373.15 K, J. Mol. Liq. 180 (2013) 252-259.[18] G.D. Yang, Y.R. Huang, G.J. Nan, H.J. Chen, A.G. Zeng, X.L. Bian, Solubility of daidzein in the binary system of ethanol and water, J. Mol. Liq. 180 (2013) 160-163.[19] F. Shakeel,M.S. Faisal, Caffeine: A potential complexing agent for solubility and dissolution enhancement of celecoxib, Pharm. Biol. 48 (2010) 113-115.[20] A.M. El-Shafae, M.M. El-Domiaty, Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations, J. Pharm. Biomed. Anal. 26 (2001) 539-545. |